Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with typ (Q53261592)
Jump to navigation
Jump to search
scientific article published in September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with typ |
scientific article published in September 2014 |
Statements
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with typ (English)
1 reference
Helena W Rodbard
1 reference
Stephen C L Gough
1 reference
Bruce Bode
1 reference
Vincent Woo
1 reference
Sultan Linjawi
1 reference
Pernille Poulsen
1 reference
Lars H Damgaard
1 reference
NN9068-3697 (DUAL-I) trial investigators
1 reference
1 September 2014
1 reference
2
1 reference
885-893
1 reference
11
1 reference
Identifiers
1 reference